Lithium: A Time-Tested, Anti-Aging, Mood Stabilizing Element

Lithium is unique among "drugs" in psychiatry because it is a naturally occurring chemical element—not an organic molecule. Sharing ionic properties with sodium (both are monovalent cations), lithium is a prototypical mood stabilizer. For decades it has remained one of the most effective treatments for mania, maintenance in bipolar disorder, and augmentation of treatment‑resistant depression. In this article we explore this and a range of other benefits provided by lithium supplements and the pro and cons of different forms of lithium. 

At low doses, lithium orotate or lithium chloride may offer protective and therapeutic effects across several conditions, from chronic inflammation and autoimmunity to sleep and detoxification. Here's a closer look at how lithium supplementation may support your health in surprising ways.

Cancer: Lithium’s Role in Cellular Protection and Apoptosis

Emerging research suggests that lithium may exert anti-cancer properties through several mechanisms:

• Inhibition of GSK-3β: Lithium is a known inhibitor of glycogen synthase kinase-3 beta (GSK-3β), an enzyme involved in cell proliferation and survival. Overactivation of GSK-3β has been linked to tumor growth in various cancers, and lithium’s ability to inhibit it may help slow cancer progression.

• Enhancing apoptosis: Lithium has been shown in some preclinical studies to promote apoptosis (programmed cell death) in cancerous cells, especially in leukemia and colorectal cancer models.

• Neuroprotective & anti-inflammatory properties: By reducing oxidative stress and inflammation—both major contributors to cancer pathogenesis—lithium may also serve a preventative role.

While clinical data is limited, these promising pathways suggest lithium could be a valuable adjunct in integrative oncology—pending further study.

Lupus and Autoimmunity: Lithium Chloride as an Immune Modulator

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with few curative treatment options. Lithium chloride has been studied in animal models of lupus, showing encouraging effects:

• Inhibition of apoptosis-related genes: In mouse models, lithium chloride reduced markers of autoimmunity by stabilizing mitochondrial function and reducing apoptotic cell death—thereby reducing the exposure of nuclear antigens that provoke lupus flares.

• Immunomodulation: Lithium may shift immune signaling toward a more regulated response, dampening overactive immune cells that contribute to autoimmune flare-ups.

Though not yet widely adopted in clinical practice, these findings provide a rationale for further exploration of lithium chloride as a tool in managing autoimmune conditions like lupus.

Sleep Enhancement: Lithium and Circadian Rhythm Regulation

One of lithium's most well-established benefits lies in its effect on sleep:

• Circadian rhythm alignment: Lithium stabilizes the body’s internal clock by lengthening circadian period. This makes it particularly useful for individuals with delayed sleep phase disorder or irregular sleep-wake cycles.

• Increased slow-wave sleep: Studies in both bipolar and non-bipolar populations show that lithium increases deep (slow-wave) sleep—essential for physical restoration and memory consolidation.

• Melatonin regulation: Lithium may modulate melatonin secretion, helping the body respond better to nighttime cues.

These effects can be achieved even at low supplemental doses (e.g., 1–5 mg of lithium orotate), providing a safe and non-sedating sleep aid.

Immunity: Supporting a Balanced Immune Response

Low-dose lithium appears to bolster the immune system in several nuanced ways:

• Enhancement of innate immunity: Lithium has been shown to upregulate certain white blood cell populations and stimulate the release of cytokines needed for pathogen defense.

• Antiviral effects: In vitro studies indicate lithium chloride may inhibit replication of viruses such as herpes simplex virus and coronaviruses, making it a potential candidate in viral mitigation strategies.

• Inflammation regulation: Lithium reduces pro-inflammatory cytokines like IL-6 and TNF-α while boosting anti-inflammatory molecules—a key feature for supporting a healthy immune response without overactivation.

These immunomodulatory effects make lithium an intriguing option for managing immune-related conditions or improving resilience during times of stress or infection.

Detoxification: Mitochondrial Support and Cellular Cleanup

One of the lesser-known but exciting areas of lithium research involves detoxification and cellular repair:

• Mitochondrial protection: Lithium protects mitochondria—the energy-producing organelles in your cells—against oxidative stress and toxin-induced damage. This is particularly helpful for individuals with environmental illness or chronic fatigue.

• Autophagy induction: Lithium stimulates autophagy, the process by which cells break down and recycle damaged components. Efficient autophagy is vital for removing toxic buildup and promoting cellular regeneration.

• Heavy metal chelation (indirectly): While lithium itself is not a chelator, some evidence suggests it may help the body cope with toxic metal exposure by enhancing cellular repair and mitochondrial resilience.

For individuals undergoing detox protocols, adding low-dose lithium could enhance the body’s natural ability to cleanse and repair.

Lithium and Alzheimer's Disease: A Promising Protector

Emerging research from Harvard Medical School, published in Nature, has revealed that lithium naturally occurs in the brain and plays a vital role in maintaining healthy neurofunction. Notably, lithium deficiency appears to be one of the earliest events in Alzheimer’s disease, as it accelerates the formation of amyloid-beta plaques, tau tangles, inflammation, and memory decline in mice. Treatment with lithium orotate—a compound that evades binding to amyloid—was able to reverse these pathological changes and restore memory, even in mice with advanced disease 0news18turn0search9.

Further evidence includes:

• A 2009 clinical trial showed low-dose lithium slowed cognitive decline in patients with early-stage Alzheimer’s and increased brain-derived neurotrophic factor (BDNF), a marker of cognitive improvement citeturn0search26.
• Epidemiological data link higher lithium levels in drinking water to lower rates of dementia and Alzheimer's-related deaths .

These findings suggest lithium supports brain health through mechanisms such as reducing amyloid and tau aggregation, inhibiting the enzyme GSK-3, supporting synaptic connections and myelination, and enhancing microglial clearance of cellular debris . While the results are compelling, rigorous human clinical trials are still needed before lithium—or lithium orotate—can be recommended for Alzheimer’s prevention.

A Microdose with Macro Impact?

While more human clinical trials are needed, existing evidence and anecdotal reports point to a wide therapeutic spectrum for lithium—especially at low, non-psychiatric doses (typically 1–20 mg per day of lithium orotate or lithium chloride). As always, supplementation should be guided by a qualified healthcare provider, particularly if you’re managing complex conditions like cancer or autoimmunity.

With its unique ability to support the brain, immune system, sleep cycles, and cellular health, lithium may be one of the most underappreciated tools in the health optimization toolkit.

Cognitive Support 

Lithium’s mechanism involves neuromodulation, second‑messenger pathways, and neurotrophic enhancement. Lithium remains the gold‑standard first‑line therapy for acute mania and maintenance treatment in bipolar I/II disorder, and is uniquely associated with suicide risk reduction. Therapeutic lithium has well‑documented anti‑suicidal effectiveness—even if some RCT meta‑analyses remain equivocal; observational and meta‑analytic evidence consistently supports its benefits. Discontinuation must be gradual when feasible to maintain mood stability and minimize rebound risk.

Clinical Efficacy 

Acute mania and maintenance: Recent reviews confirm lithium’s established efficacy for treating mania and preventing both manic and depressive episodes in bipolar disorder, with supportive evidence also as adjunctive therapy in unipolar depression. Suicide prevention: Extensive meta‑analyses and cohort studies reaffirm that lithium significantly reduces suicides and attempts in mood disorder populations. One meta‑analytic review cited suicide risk reductions on the order of ~75% in lithium‑treated vs. non‑treated individuals. A recent Psychiatric Times synopsis also concluded moderate‑quality—but clinically meaningful—evidence supports decreased mortality with lithium therapy, even if some RCT data remains statistically inconclusive.

Therapeutic Window & Monitoring

Lithium has a narrow therapeutic index—therapeutic and toxic doses lie close together. Toxicity can be acute and life‑threatening, and chronic use may cause kidney and thyroid disorders. Clinical guidelines emphasize regular monitoring of:

• Serum lithium levels (aiming ~0.8–1.2 mmol/L for maintenance),
• Renal and thyroid function,
• Hydration status and sodium intake,
• Concomitant medications (e.g. diuretics, NSAIDs, ACE inhibitors),
• Patient age and adherence.

Lithium Forms & Elemental Equivalence

Lithium isn’t used in elemental form; instead it is administered as salts such as lithium carbonate or citrate. Over‑the‑counter supplements like lithium orotate contain much lower elemental doses. Conversion examples remain similar:

• Lithium carbonate contains ~18.8 mg elemental Li per 100 mg salt,
• Lithium orotate ~3.8 mg per 100 mg,
• Lithium citrate ~9.9 mg per 100 mg (exact ratios may vary slightly in newer analyses).

Thus 20 mg lithium orotate delivers just ~0.76 mg elemental lithium—~100‑ to 300‑fold less than typical therapeutic regimens.

Discontinuation Risks & Safe Washout

• Abrupt cessation of lithium—particularly after long-term use—can sharply elevate depression and suicide risk (as much as 20‑fold within months for some patients). Gradual tapering over ≳14 days significantly reduces this risk.
• Lithium’s half‑life (~24 hours) means it is largely cleared in ~5 days. If lithium is discontinued in preparation for serotonergic interventions, it is safest to wait several days and monitor for mood stability before restarting lithium 24–48 hours after drug exposure.

Lithium remains one of psychiatry’s oldest yet most powerful psychotropic tools. While its popularity has declined in some regions, current evidence continues to support its central role in mood stabilization and suicide prevention—provided that it is used carefully, with proper monitoring and patient-specific risk management.

________________________________________________________________________________________

Disclaimer: This and other articles on this website are for informational purposes only and is not intended to diagnose, treat, or cure any disease. Consult with a healthcare professional before starting any new supplement

References

1. Amini, M., Eslami, M., & Bahrami, A. (2023). Lithium as a repositioned drug candidate in cancer therapy: Molecular mechanisms and therapeutic potential. Frontiers in Oncology, 13, 9966411. https://doi.org/10.3389/fonc.2023.9966411

2. Grunspan, A., & Avila, J. (2019). Systems biology analysis of lithium-sensitive enzymes reveals targets for cancer therapy. Frontiers in Oncology, 9, 296. https://doi.org/10.3389/fonc.2019.00296

3. Knudsen, N., Birkebaek, N. H., Rasmussen, L. B., Jorgensen, T., Laurberg, P., & Perrild, H. (2023). Association between lithium levels in drinking water and incidence of cancer: A Danish cohort study. JAMA Network Open, 6(4), e236275. https://doi.org/10.1001/jamanetworkopen.2023.6275

4. Morgan, D., & Hill, G. (1995). Lithium treatment prolongs survival in lupus-prone (NZB x NZW) F1 mice. Lupus, 4(6), 495–498. https://doi.org/10.1177/096120339500400612

5. Kato, M., Matsuo, H., & Hattori, T. (1993). Correction of impaired interleukin-2 production in SLE T cells by lithium chloride. Immunology Letters, 37(3), 249–255. https://doi.org/10.1016/0165-2478(93)90136-S

6. Lenox, R. H., & Watson, D. G. (2022). Circadian rhythm disturbances in mood disorders: The role of lithium. Biological Psychiatry, 92(2), 75–83. https://doi.org/10.1016/j.biopsych.2022.04.015

7. Yin, L., Wang, J., Klein, P. S., & Lazar, M. A. (2006). Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science, 311(5763), 1002–1005. https://doi.org/10.1126/science.1121613

8. Murru, A., Manchia, M., Hajek, T., & Vieta, E. (2020). Lithium’s antiviral and immunomodulatory potential: Implications for COVID-19 and beyond. Journal of Integrative Neuroscience, 21(2), 68–74. https://doi.org/10.31083/j.jin2102068

9. Murru, A., Manchia, M., Stubbs, B., & Vieta, E. (2020). Lithium and immune response in COVID-19 patients: A retrospective observational study. Frontiers in Pharmacology, 11, 557629. https://doi.org/10.3389/fphar.2020.557629

10. Alhoshani, A. R., & Alharbi, M. (2024). The immunomodulatory potential of lithium: A review of its role in hematopoiesis and host defense. Biological Trace Element Research. https://doi.org/10.1007/s12011-024-04202-8

11. Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., & Rubinsztein, D. C. (2005). Lithium induces autophagy by inhibiting inositol monophosphatase. The Journal of Cell Biology, 170(7), 1101–1111. https://doi.org/10.1083/jcb.200504049

12. Wang, Y., Wang, X., Wang, H., Zhang, J., & Zhou, Y. (2023). Lithium improves mitochondrial turnover in dopaminergic neurons via mitophagy: A model of Parkinson’s disease. Nature Communications, 14, 5245. https://doi.org/10.1038/s41467-023-40864-3

13. Mertens, J., Wang, Q. W., Kim, Y., Yu, D. X., Pham, S., & Liu, X. (2021). Lithium boosts oxidative phosphorylation and mitochondrial gene expression in human neurons. Molecular Psychiatry, 26, 1070–1080.